PE Ratio
133.76
+6.86+5.41%
Fri, 03 Jan 2025 00:05:57 GMT
Summary:
Castle Biosciences price to earnings ratio is currently 133.76, with a rise of +6.86 (+5.41%) during the most recent trading day. CSTL PE ratio is now -86.47% below its all-time high of 988.74.CSTL PE Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL PE Ratio Performance
| PeriodPeriod | PE ratioPE ratio | PricePrice | TTM EPSTTM EPS | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | +5.4% | +5.4% | +261.5% | +8.4% |
| 1 m1 month | -10.5% | -10.5% | - | - |
| 3 m3 months | -1.3% | -1.3% | - | - |
| 6 m6 months | - | +32.1% | - | - |
| ytdytd | +5.4% | +5.4% | - | - |
| 1 y1 year | - | +28.0% | +109.8% | +41.9% |
| 5 y5 years | - | -16.9% | +201.7% | +501.3% |
CSTL PE Ratio High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 149.52 | -10.5% | 119.05 | +12.4% |
| 3 m | 3 months | 166.67 | -19.8% | 119.05 | +12.4% |
| 6 m | 6 months | 166.67 | -19.8% | 119.05 | +12.4% |
| 1 y | 1 year | 166.67 | -19.8% | 119.05 | +12.4% |
| 3 y | 3 years | 166.67 | -19.8% | 119.05 | +12.4% |
| 5 y | 5 years | 988.74 | -86.5% | 119.05 | +12.4% |
| alltime | all time | 988.74 | -86.5% | 119.05 | +12.4% |
Castle Biosciences PE Ratio History
| Date | Value |
|---|---|
| 2025 | 133.76(+5.4%) |
| Date | Value |
|---|---|
| 2024 | 126.90 |
FAQ
- What is Castle Biosciences price to earnings ratio?
- What is the all time high PE ratio for Castle Biosciences?
- What is CSTL price to earnings ratio year-to-date change?
What is Castle Biosciences price to earnings ratio?
The current PE ratio of CSTL is 133.76
What is the all time high PE ratio for Castle Biosciences?
Castle Biosciences all-time high price to earnings ratio is 988.74
What is CSTL price to earnings ratio year-to-date change?
Castle Biosciences price to earnings ratio has changed by +6.86 (+5.41%) since the beginning of the year